期刊文献+

玻璃体腔注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿的临床观察 被引量:10

Intravitreal injection of conbercept for macular edema secondary to retinal vein occlusion
原文传递
导出
摘要 目的探讨玻璃体腔注射康柏西普治疗视网膜静脉阻塞(retinal vein occlusion,RVO)继发黄斑水肿(macular edema,M E)的有效性。方法采用前瞻性连续性非对照的临床病例分析。选择2014年9月至2015年2月就诊的RVO继发ME 30例30眼,其中视网膜中央静脉阻塞(central retinal vein occlusion,CRVO)继发的ME 9例9眼,视网膜分支静脉阻塞(branch retinal vein occlusion,BRVO)继发的ME 21例21眼。玻璃体腔注射康柏西普治疗3次,随访6个月,观察最佳矫正视力(best corrected visual acuity,BCVA)、黄斑中心凹视网膜厚度(central macular thickness,CM T)。结果 BRVO患眼治疗前及治疗后6个月BCVA分别为(0.77±0.24)log M AR、(0.27±0.19)log M AR,CM T分别为(596.8±139.6)μm、(272.6±29.2)μm,差异具有显著统计学意义(t=4.483,P<0.05;t=7.189,P<0.05);CRVO患眼治疗前及治疗后6个月BCVA分别为(0.87±0.55)log M AR、(0.43±0.2)log M AR,CM T分别为(647.3±163.6)μm、(393.1±121.5)μm,差异具有显著统计学意义(t=2.288,P<0.05;t=7.189,P<0.05)。结论玻璃体腔注射康柏西普是一种治疗RVO继发M E的有效方式。 Objective To explore the effects of intravitreal injection of conbercept for macular edema( ME) secondary to retinal vein occlusion( RVO). Methods A prospective,continuity and uncontrolled clinical case analysis was used. Thirty cases( 30 eyes) with ME secondary to RVO in our hospital from September 2014 to February 2015 were selected,in which 9 cases( 9 eyes) were central retinal vein occlusion( CRVO) and 21 cases( 21 eyes) were branch retinal vein occlusion( BRVO). All cases were treated with intravitreal injection of conbercept for 3 times and followed up for 6 months. Best corrected visual acuity( BCVA) and central macular thickness( CMT) were observed. Results In patients with BRVO,mean BCVA before treatment and 6 months after treatment were( 0. 77 ± 0. 24) log MAR,( 0. 27 ± 0. 19) log MAR,and CMT were( 596. 8 ± 139. 6) μm,( 272. 6 ± 29. 2) μm,respectively,the difference has statistical significance( t = 4. 483,P〈0. 05; t = 7. 189,P〈0. 05). In patients with CRVO,mean BCVA before treatment and 6 months after treatment were( 0. 87 ± 0. 55) log MAR,( 0. 43 ± 0. 2) log MAR,and CMT were( 647. 3 ±163. 6) μm,( 393. 1 ± 121. 5) μm,respectively,the difference has statistical significance( t = 2. 288,P〈0. 05; t =7. 189,P〈0. 05). Conclusion Intravitreal injections of conbercept is effective for ME secondary to RVO.
出处 《山东大学耳鼻喉眼学报》 CAS 2016年第4期105-108,共4页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 玻璃体腔注射 视网膜静脉阻塞 黄斑水肿 康柏西普 Intravitreal injection Retinal vein occlusion Macular edema Conbercept
  • 相关文献

参考文献9

  • 1Klein R, Klein B E, Moss S E, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study[ J]. Trans Am Ophthalmol Soc, 2000, 98:133-141.
  • 2Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion [J]. Arch Ophthalmol, 1992, 110(10) :1427-1434.
  • 3乔森(著),陈有信(译).视网膜血管性疾病[M].北京:科学出版社,2011:423.
  • 4Klein M L, Finkelstein D. Macular grid photocoagulation for rnacular edema in central retinal vein occlusion [ J ]. Arch Ophthalmol, 1989, 107(9) :1297-1302.
  • 5Parodi M B, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion[ J]. Graefe's Ar- chive for Clinical and Experimental Ophthalmology, 1999 (12) : 1024-1027.
  • 6Jonas J B, Kreissig I, Kamppeter B, et al. Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases [ J ]. Ophthalmologe, 2004, 101(2) :113-120.
  • 7Noma H, Minamoto A, Funatsu H, et al. Intravitreal lev- els of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion [ J]. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, 244 ( 3 ) : 309- 315.
  • 8Brown D M, Campochiaro P A, Bhisitkul R B, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month out- comes of a phase III study [ J]. Ophthalmology, 2011, 118(8) :1594-1602.
  • 9Campochiaro P A, Brown D M, Awh C C, et al. Sus- tained benefits from ranibizumab for macular edema fol- lowing central retinal vein occlusion: twelve-month out- comes of a phase III study [J]. Ophthalmology, 2011, 118 ( 10 ) : 2041-2049.

同被引文献69

引证文献10

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部